UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies

Nature reviews. Endocrinology, 2017-11, Vol.13 (11), p.644-660

2017

Volltextzugriff (PDF)

Editorial: News in Graves’ orbitopathy: patients management and treatments

Frontiers in endocrinology (Lausanne), 2023-08, Vol.14, p.1270467

2023

Volltextzugriff (PDF)

Oxidative phosphorylation in bone cells

Bone Reports, 2023-06, Vol.18, p.101688-101688, Article 101688

2023

Volltextzugriff (PDF)

The hypoxia signature across skeletal progenitor cells

Journal of bone and mineral research, 2024-05, Vol.39 (4), p.373-374

2024

Volltextzugriff (PDF)

Сytotoxic T lymphocyte-associated protein 4 (CTLA4) is overexpressed in a subset of prolactin- and growth hormone-secreting pituitary adenomas

Endocrine-related cancer, 2024-01, Vol.31 (1)

2024

Volltextzugriff (PDF)

Lenvatinib and other tyrosine kinase inhibitors for the treatment of radioiodine refractory, advanced, and progressive thyroid cancer

OncoTargets and therapy, 2016-01, Vol.9, p.6467-6477

2016

Volltextzugriff (PDF)

MyMD-1 Improves Health Span and Prolongs Life Span in Old Mice: A Noninferiority Study to Rapamycin

The journals of gerontology. Series A, Biological sciences and medical sciences, 2023-02, Vol.78 (2), p.227-235

2023

Volltextzugriff (PDF)

Occurrence of Graves’ Orbitopathy and Graves’ Hyperthyroidism after a Trauma to the Eye

European thyroid journal, 2018-01, Vol.7 (1), p.51-54

2018

Volltextzugriff (PDF)

Distinct Cytokine Signatures in Thyroiditis Induced by PD-1 or CTLA-4 Blockade: Insights from a New Mouse Model

Thyroid (New York, N.Y.), 2021-12, Vol.31 (12), p.1839-1849

2021

Volltextzugriff (PDF)

Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial

The lancet. Diabetes & endocrinology, 2021-11, Vol.9 (11), p.733-742

2021

Volltextzugriff (PDF)

Pre-existing Thyroiditis Ameliorates Papillary Thyroid Cancer: Insights From a New Mouse Model

Endocrinology (Philadelphia), 2021-10, Vol.162 (10), p.1

2021

Volltextzugriff (PDF)

Association of T and B Cells Infiltrating Orbital Tissues With Clinical Features of Graves Orbitopathy

JAMA ophthalmology, 2018-06, Vol.136 (6), p.613

2018

Volltextzugriff (PDF)

Treatment of advanced thyroid cancer with targeted therapies: ten years of experience

Endocrine-related cancer, 2016-04, Vol.23 (4), p.R185-R205

2016

Volltextzugriff (PDF)

High Serum Cholesterol Is a Novel Risk Factor for Graves' Orbitopathy: Results of a Cross-Sectional Study

Thyroid (New York, N.Y.), 2018-03, Vol.28 (3), p.386-394

2018

Volltextzugriff (PDF)

Pre-existing Thyroid Autoimmunity and Risk of Papillary Thyroid Cancer: A Nested Case-Control Study of US Active-Duty Personnel

Journal of clinical oncology, 2022-08, Vol.40 (23), p.JCO2102618-2587

2022

Volltextzugriff (PDF)

Osteoblastic erythropoietin is not required for bone mass accrual

JBMR plus, 2024-06, Vol.8 (6), p.ziae052-ziae052

2024

Volltextzugriff (PDF)

VARIABLES AFFECTING THE LONG-TERM OUTCOME OF GRAVES ORBITOPATHY FOLLOWING HIGH-DOSE INTRAVENOUS GLUCOCORTICOID PULSE THERAPY IN PATIENTS NOT TREATED WITH ORBITAL RADIOTHERAPY

Endocrine practice, 2016-10, Vol.22 (10), p.1177

2016

Volltextzugriff (PDF)

Erythropoietin and skeletal cells crosstalks in physiology and disease

Current opinion in endocrine and metabolic research, 2023-04, Vol.29, p.100436, Article 100436

2023

Volltextzugriff (PDF)

Acromegaly in the setting of Tatton-Brown-Rahman Syndrome

Pituitary, 2020-04, Vol.23 (2), p.167-170

2020

Volltextzugriff (PDF)

HIF1 activation safeguards cortical bone formation against impaired oxidative phosphorylation

JCI insight, 2024-08, Vol.9 (18)

2024

Volltextzugriff (PDF)

Natural history of graves’ orbitopathy after treatment

Endocrine, 2017-08, Vol.57 (2), p.226-233

2017

Volltextzugriff (PDF)

Does Graves’ Orbitopathy Ever Disappear Answers to an Old Question

European thyroid journal, 2017-09, Vol.6 (5), p.263-270

2017

Volltextzugriff (PDF)

VARIABLES AFFECTING THE LONG TERM OUTCOME OF GRAVES' ORBITOPATHY FOLLOWING HIGH DOSE INTRAVENOUS GLUCOCORTICOID PULSE THERAPY IN PATIENTS NOT TREATED WITH ORBITAL RADIOTHERAPY

Endocrine practice, 2016-10, Vol.22 (10), p.1177-1186

2016

Volltextzugriff (PDF)

VARIABLES AFFECTING THE LONG-TERM OUTCOME OF GRAVES ORBITOPATHY FOLLOWING HIGH-DOSE INTRAVENOUS GLUCOCORTICOID PULSE THERAPY IN PATIENTS NOT TREATED WITH ORBITAL RADIOTHERAPY

Endocrine practice, 2016-10, Vol.22 (10), p.1177

2016

Volltextzugriff (PDF)

A large series of patients with anaplastic thyroid cancer managed in a tertiary referral center

Endocrine Abstracts, 2023-08

2023

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(25)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Endocrine Practice
(3)
Endocrine-Related Cancer
(2)
European Thyroid Journal
(2)
Thyroid
(2)
Advances In Therapy
(1)
Bone Reports
(1)
Current Opinion In Endocrine And Metabolic Research
(1)
Endocrine
(1)
Endocrine Abstracts
(1)
Endocrinology
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies

Editorial: News in Graves’ orbitopathy: patients management and treatments

Oxidative phosphorylation in bone cells

The hypoxia signature across skeletal progenitor cells

Сytotoxic T lymphocyte-associated protein 4 (CTLA4) is overexpressed in a subset of prolactin- and growth hormone-secreting pituitary adenomas

Lenvatinib and other tyrosine kinase inhibitors for the treatment of radioiodine refractory, advanced, and progressive thyroid cancer

MyMD-1 Improves Health Span and Prolongs Life Span in Old Mice: A Noninferiority Study to Rapamycin

Occurrence of Graves’ Orbitopathy and Graves’ Hyperthyroidism after a Trauma to the Eye

Distinct Cytokine Signatures in Thyroiditis Induced by PD-1 or CTLA-4 Blockade: Insights from a New Mouse Model

Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial

Pre-existing Thyroiditis Ameliorates Papillary Thyroid Cancer: Insights From a New Mouse Model

Association of T and B Cells Infiltrating Orbital Tissues With Clinical Features of Graves Orbitopathy

Treatment of advanced thyroid cancer with targeted therapies: ten years of experience

High Serum Cholesterol Is a Novel Risk Factor for Graves' Orbitopathy: Results of a Cross-Sectional Study

Pre-existing Thyroid Autoimmunity and Risk of Papillary Thyroid Cancer: A Nested Case-Control Study of US Active-Duty Personnel

Osteoblastic erythropoietin is not required for bone mass accrual

VARIABLES AFFECTING THE LONG-TERM OUTCOME OF GRAVES ORBITOPATHY FOLLOWING HIGH-DOSE INTRAVENOUS GLUCOCORTICOID PULSE THERAPY IN PATIENTS NOT TREATED WITH ORBITAL RADIOTHERAPY

Erythropoietin and skeletal cells crosstalks in physiology and disease

Acromegaly in the setting of Tatton-Brown-Rahman Syndrome

HIF1 activation safeguards cortical bone formation against impaired oxidative phosphorylation

Natural history of graves’ orbitopathy after treatment

Does Graves’ Orbitopathy Ever Disappear Answers to an Old Question

VARIABLES AFFECTING THE LONG TERM OUTCOME OF GRAVES' ORBITOPATHY FOLLOWING HIGH DOSE INTRAVENOUS GLUCOCORTICOID PULSE THERAPY IN PATIENTS NOT TREATED WITH ORBITAL RADIOTHERAPY

VARIABLES AFFECTING THE LONG-TERM OUTCOME OF GRAVES ORBITOPATHY FOLLOWING HIGH-DOSE INTRAVENOUS GLUCOCORTICOID PULSE THERAPY IN PATIENTS NOT TREATED WITH ORBITAL RADIOTHERAPY

A large series of patients with anaplastic thyroid cancer managed in a tertiary referral center

Suchergebnisse filtern